Lose Fat, Not Muscle: Next Test for Lilly’s Zepbound Pairs It With BioAge Drug Medcity News, 25 Feb 2024 One concern about the GLP-1 class of metabolic disorder drugs is that the weight patients lose includes muscle as well as fat.